A detailed history of Investmark Advisory Group LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Investmark Advisory Group LLC holds 26,092 shares of ABBV stock, worth $4.43 Million. This represents 2.55% of its overall portfolio holdings.

Number of Shares
26,092
Previous 25,745 1.35%
Holding current value
$4.43 Million
Previous $4.42 Million 16.69%
% of portfolio
2.55%
Previous 2.4%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$163.84 - $199.33 $56,852 - $69,167
347 Added 1.35%
26,092 $5.15 Million
Q2 2024

Aug 14, 2024

SELL
$154.79 - $180.76 $44,424 - $51,878
-287 Reduced 1.1%
25,745 $4.42 Million
Q1 2024

May 17, 2024

SELL
$159.82 - $182.1 $177,400 - $202,131
-1,110 Reduced 4.09%
26,032 $4.74 Million
Q4 2023

Feb 14, 2024

BUY
$137.6 - $154.97 $58,755 - $66,172
427 Added 1.6%
27,142 $4.21 Million
Q2 2023

Aug 14, 2023

BUY
$132.51 - $164.9 $19,876 - $24,735
150 Added 0.56%
26,715 $3.6 Million
Q1 2023

May 15, 2023

BUY
$144.61 - $166.54 $62,616 - $72,111
433 Added 1.66%
26,565 $4.23 Million
Q4 2022

Jan 24, 2023

BUY
$138.31 - $165.87 $80,634 - $96,702
583 Added 2.28%
26,132 $0
Q3 2022

Nov 14, 2022

BUY
$134.21 - $153.93 $81,465 - $93,435
607 Added 2.43%
25,549 $3.43 Million
Q2 2022

Jul 15, 2022

BUY
$137.62 - $174.96 $36,606 - $46,539
266 Added 1.08%
24,942 $3.82 Million
Q1 2022

May 03, 2022

BUY
$131.98 - $163.75 $60,182 - $74,670
456 Added 1.88%
24,676 $4 Million
Q4 2021

May 03, 2022

BUY
$107.43 - $135.93 $2.6 Million - $3.29 Million
24,220 New
24,220 $3.28 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $300B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Investmark Advisory Group LLC Portfolio

Follow Investmark Advisory Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Investmark Advisory Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Investmark Advisory Group LLC with notifications on news.